The 20th Anniversary PSC Partners Annual Conference took place in Phoenix, Arizona, on October 18-20, 2024. Throughout the conference weekend, more than 360 attendees were reminded of how far PSC Partners has come as an organization in the past 20 years and of the accelerating progress of PSC research.
Evidence of that progress included the second gathering of the International Collaborative Research Network (ICRNetwork), which met prior to the general patient/caregiver conference. The ICRNetwork, launched in June 2022, is a group of key stakeholders, including researchers, clinicians, patients, and industry members, that was formed in response to PSC Partners’ focused efforts to forge a strategic research plan. Many of the ICRN members were speakers for the patient/caregiver sessions and presented up-to-date information on PSC management and research advances.
One of the general sessions, “Industry Updates: Ongoing PSC Clinical Trials,” included reports by pharmaceutical representatives about several trials for which the Registry has assisted with trial design and/or recruitment, and in which some of you have participated. Presenters sharing updates about their PSC drug trials included Chemomab Therapeutics, Intercept Pharmaceuticals, Ipsen Biopharmaceuticals, Mirum Pharmaceuticals, and Pliant Therapeutics. You can find more information about their trials on the Clinical Trials page.
Chemomab and Pliant gave similar presentations a few weeks later at “The Liver Meeting,” an annual global convening of hepatologists and other experts from around the world, sponsored by the American Association for the Study of Liver Diseases. Each presented late-breaking posters about their trial drug results. You can read the news releases and view the posters at the links below.
The conference weekend was filled with enthusiasm as both PSC Partners and its Registry celebrated their respective anniversaries amid a growing sense of hope for the future of PSC research and much improved PSC treatments.
